Age-Related Percutaneous Penetration of 2-sec-Butyl-4,6-dinitrophenol (Dinoseb) in Rats

[¹⁴C]Dinoseb was applied to previously clipped back skin of33- and 82-day-old female Fischer 344 rats at a dosage rangeof 210–2680 nmol/cm². Radioactivity in the treated skin,tissues, urine, and feces was determined at 1, 6, 24, 48, 72,and 120 hr following dermal application. In vitro dermal absorptionof [¹⁴C]dinoseb was also measured in rats of the same age bystatic and flow-through methods. In vivo dermal absorption inboth young and adults appeared biphasic with 55.6 and 82.7%of the recovered dose, respectively, penetrating in 72 hr. Invitro measurements of skin absorption at 72 hr with static cellsshowed higher values in young and lower values in the adultcompared to in vivo dermal absorption values, In vitro flow-throughmeasurements at 72 hr gave lower dermal absorption values forboth young and adult rats, compared to In vivo values. Followingin vivo application, adults excreted about 70% of the totalrecovered dose in urine, 16% in feces, and retained 7% in thebody at 120 hr. HPLC analysis of urine collected at 24 hr fromadults administered [¹⁴C]dinoseb showed extensive metabolismof parent. Excretion and retention results for young were about80% of the adult values, which also was the young to adult ratioof dermal penetration. Blood had the highest concentration ofdinoseb-derived radioactivity of the tissues examined. The kidneyto blood ratio averaged 0.60 in young and 0.41 in adults, whilethe liver and carcass to blood ratio averaged 0.18 in youngand 0.11 in adult. Dermal absorption in young rats was slightlyless than that in adults, and the subsequent kinetics of retentionand excretion appeared different, In vitro dermal penetrationof dinoseb was usually lower than In vivo absorption.     

Dermal absorption of chemicals: effect of application of chemicals as a solid, aqueous paste, suspension, or in volatile vehicle.

The purpose of this study was to investigate the dermal absorption of chemicals in different physical forms when applied to female F344 rats. Chemicals were applied either as a solid, aqueous paste, suspension, or dissolved in the volatile vehicle ethanol. The chemicals investigated were [14C]-2-sec-butyl-4,6-dinitrophenol (DNBP, 4.2 mumol), 2,4,5,2',4',5'-[14C]-hexachlorobiphenyl (HCB, 2.3 mumol), and 3,4,3',4'-[14C]-tetrachlorobiphenyl (TCB, 0.5 mumol). The chemicals were applied on the clipped mid-dorsal region of the rat over a 2.54-cm2 treatment area, which was then occluded. Urine and feces were collected and assayed for radioactivity. Twenty-four hours post-application, the treated skin was washed with a mixture (1:1) of soap and water, dried, and reoccluded. The animals were sacrificed at 120 h by exsanguination under ether anesthesia. Radioactivity in the blood, skin (treated and untreated), and carcass was assayed. Dermal absorption of DNBP-derived radioactivity was approximately 50% of the recovered dose after application in the four physical forms, and the major route of excretion was via the urine. Twelve percent of the absorbed dose of DNBP was retained in the body. Dermal penetration of HCB-derived radioactivity was 5-8% of the recovered dose after application in the four forms, and the major route of excretion was via the feces. Greater than 90% of the absorbed dose of HCB-derived radioactivity was retained in the body. Dermal penetration of TCB-derived radioactivity was 6-8% of the recovered dose in the four forms, and the major route of excretion was via the feces. Approximately 21% of the absorbed dose was retained in the body at 120 h. Absorption of each chemical applied either as solid, aqueous paste, or suspension was compared to the absorption of the same chemical in ethanol. Absorption of HCB applied as a solid was significantly higher (p less than or equal to .05) as compared to HCB applied in ethanol. There were no other significantly differences in the comparisons of absorption. The data indicate that the chemicals examined in this study can penetrate the skin as readily when applied either as a solid, aqueous paste, or suspension, as when applied in the volatile vehicle ethanol.     

Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C]pyrrolidinone in the rat.

The percutaneous absorption has been investigated in rats of a mixture (3:2, w/w) of N-methyl-2-pyrrolidinone (NMP) and 2-pyrrolidinone (2-P), a combination intended for use as a vehicle in the formulation of an antimycotic drug to enhance skin penetration on dermal application, following co-administration of the two 14C-radiolabelled compounds by the dermal and oral routes. Radioactivity was excreted predominantly in the urine after either route of administration, and comparison of the respective excretion profiles indicated that about three-quarters of the applied dose was absorbed through the skin. Plasma concentrations of each parent compound, as determined by radio-HPLC, reached peak values at 2 hr after oral dosing, and remained relatively uniform during 1-6 hr after application to the skin, suggesting constant percutaneous absorption during this period. NMP appeared to be absorbed through the skin more extensively and at a slightly faster rate than 2-P; total percutaneous absorption tended to be more extensive in female than in male rats. Together, these two 14C-compounds accounted for most of the plasma radioactivity up to 6-8 hr post-administration. However, by 12 hr (when plasma levels were relatively low), most of the radioactivity was associated with unknown polar metabolites. In view of the extensive percutaneous absorption and little first-pass metabolism of the two pyrrolidinones, the oral route was considered to represent a valid alternative to the dermal route for the assessment of the systemic toxicity of the two compounds.     

Dermal absorption of the phenoxy herbicide 2,4-D dimethylamine in humans: effect of DEET and anatomic site.

Percutaneous absorption of the 14C-ring-labeled phenoxy herbicide 2,4-D-amine (2,4-dichlorophenoxyacetic acid dimethylamine) was examined following topical applications of the herbicide to the palm and forearm of human volunteers. The effect of two vehicles (water and acetone) and the mosquito repellent DEET (N,N-diethyl-m-toluamide) on dermal absorption of 2,4-D-amine also was investigated. The total percent dermal absorption was calculated from the mean percent urinary recoveries and was not corrected for nonurinary excretion. The data revealed 14 +/- 4.5% (standard deviation) and 10 +/- 11.5% palmar absorption of 2,4-D-amine applied in water, with and without DEET, respectively, and 7 +/- 6.2% and 13 +/- 5.0% forearm absorption of the herbicide applied in water or acetone, respectively. Soap-and-water skin washes conducted at 24 h posttreatment removed up to 34% of the applied dose. Successive tape strips of skin taken at 24 h posttreatment demonstrated generally decreasing herbicide levels in the outer layers. The data bring into question the complete validity of the rhesus monkey model to predict human dermal absorption.     

Microencapsulation decreases the skin absorption of N,N-diethyl-m-toluamide (DEET).

The insect repellent N,N-diethyl-3-methylbenzamide (DEET) is widely used and is generally regarded as safe when used according to label instructions. Yet many studies have shown it to be absorbed through the skin. The objective of this study was to determine whether the skin absorption rate of DEET could be decreased while maintaining an evaporation rate consistent with effective repellency. To this end, an aqueous suspension containing 14C-DEET (15%w/w) entrapped in walled polysaccharide microcapsules was prepared and tested for skin absorption in vitro using modified Franz cells maintained in a fume hood. The control formulation was 15%w/w DEET in ethanol. Two doses (3 microL and 5 microL per 0.79 cm2 cell) of each formulation were applied to split-thickness human cadaver skin (n=8/dose), and permeation was monitored for 24h. The microencapsulated DEET formulation lead to a 25-35% reduction of radiolabel permeation compared to the ethanolic DEET formulation. Skin levels of radioactivity at 24h were comparable, indicating that DEET evaporation from the microencapsulated formulation was comparable to or greater than that from ethanol. Hence microencapsulation increased the ratio of DEET evaporation rate to skin penetration rate relative to unencapsulated control in this in vitro study.     

Absorption, distribution, metabolism and excretion of intravenously and dermally administered triethanolamine in mice.

Triethanolamine (TEA) is an amino alcohol having widespread applications in consumer goods and as an industrial chemical. A number of relatively high-dose dermal toxicity studies have been conducted in rats and mice reflecting the principal route of human exposure to TEA. The absorption, distribution, metabolism and excretion (ADME) of (14)C-TEA derived radioactivity were determined in male C3H/HeJ mice following dermal application of 2000 mg/kg (neat) or, to characterize blood kinetics, intravenous (iv) injection of 1 mg/kg (14)C-TEA. Balance and excretion data were also collected in mice utilizing several dermal dosing scenarios (1000 mg/kg in acetone, 2000 mg/kg neat, 2000 mg/kg in water) and, for comparative purposes, in male Fischer 344 rats dosed dermally with 1000 mg/kg neat (14)C-TEA. Urine, feces, expired CO(2) (iv) and, where appropriate, blood were collected over a 24- or 48-hour period post-dosing. The half-life for dermal absorption of radioactivity was estimated to be 1.3 hours. Intravenously administered radioactivity was eliminated in a biphasic manner with a prominent initial phase (half-life of 0.3 hr) followed by a slower terminal phase (half-life of 10 hr). Radioactivity was excreted primarily via the urine (49-69%) as unmetabolized TEA, regardless of dosage, route or vehicle used. Fecal excretion of radioactivity comprised 16-28% of dose administered. The body burden at sacrifice (sum of liver, kidney, carcass and non-application site skin) ranged from 3 to 6% of the dose. It was concluded that TEA is absorbed extensively following dermal application to mice at dosages relevant to toxicity testing and that acetone or water vehicles do not appear to significantly alter total uptake. Significantly, the blood kinetics and ADME of TEA in mice and/or rats differs from that of a related chemical, diethanolamine, which appears to be more toxic to rodents than TEA.     

DEET (N,N-diethyl-m-toluamide) alone and in combination with permethrin increased urinary excretion of 6beta-hydroxycortisol in rats, a marker of hepatic CYP3A induction.

In this study, the ratio of 6beta-hydroxycortisol (6beta-OHF) to free cortisol (F) was determined in urine following a single dermal dose of 400 mg/kg of DEET (N,N-diethyl-m-toluamide), and 1.3 mg/kg of permethrin, alone and in combination, in rats. Urine samples were collected at 2, 4, 8, 16, 24, 48, and 72 h after application. Recoveries of 6beta-OHF and cortisol (F) from control urine samples were between 75 and 85%, with limits of detection at 30 and 10 ng/ml for cortisol and 6beta-OHF, respectively. A single dermal dose of DEET alone and in combination with permethrin significantly increased urinary excretion of 6beta-hydroxycortisol 24 h after dosing. Permethrin did not significantly alter the urinary excretion of 6beta-hydroxycortisol. These results indicate that DEET, alone and in combination with permethrin, increased urinary excretion of 6beta-OHF in rats following a single dermal dose application.     

In Vivo and in Vitro Percutaneous Absorption and Skin Evaporation of Isofenphos in Man

Studies were done to determine the percutaneous absorption ofisofenphos in human volunteers from whom informed consent hadbeen obtained. In vivo absorption in man was 3.6±3.6%of applied dose for 24-hr exposure and 3.6±0.5% for 72-hrexposure. Skin wash recovery data show that isofenphos evaporatesfrom in vivo skin during the absorption process; the surfacedose is minimal (<1%) by 24 hr. Skin stripping showed noresidual isofenphos in stratum corneum. This explains the similarabsorption for 24 and 72-hr dose prewash exposures. Skin surfacerecovery in vivo with soap and water was 61.4±10.4 forthe first dosing time (15 mm). Time-recovery response declinedwith time to 0.5±0.2% at 24 hr. In vitro absorption utilizingflow-through diffusion methodology with human cadaver skin andhuman plasma receptor fluid gave 2.5±2.0% dose absorbed,an amount similar to In vivo studies. An additional 6.5±24%was recovered in the skin samples (total of 9%). Skin surfacewash at 24 hr recovered 79.7±2.2% and skin content was6.5±2.4% (total dose accountability of 88.7±4.6%).Thus, isofenphos was available for absorption during the wholedosing period. Neither in vitro absorption nor in vitro evaporationstudies predicted the potential skin evaporation of isofenphos.Published dermal studies in the rat had predicted isofenphosabsorption at 47% of applied dose (12-fold greater than actualin man). Subsequent toxicokinetic modeling predicted possibleconcern with the use of isofenphos. This is an example wherethe choice of the rat produced a nonrelevant absorption prediction.In vivo studies in human volunteers seem more relevant for predictingpercutaneous absorption in man.     

Absorption and Mass Balance of Mgk R11 and Mgk R11 Formulated with Deet,Mgk 264, and Mgk 326 Following an 8 Hour Dermal Exposure in Human Volunteers

Abstract

Dermal absorption and excretion of MGK R11 [2,3:4,5-bis(2-butylene) tetrahydro-2 furaldehyde, McLaughlin Gormley King Company, Minneapolis, MN] was studied using [¹⁴C]MGK R11 either by itself or formulated with DEET (N,N-diethyl-m-toluamide), MGK 264 (N-octylbicycloheptene dicarboximide), and MGK 326 (di-n-propyl-isocinchomeronate). Each of these two formulations was tested on four young, healthy male volunteers, using a single topical application on the forearm under nonocclusive conditions for an 8 h period. Blood from the ipsilateral and contralateral arms, urine, and feces were collected at selected intervals during the 8 h application and through a 120 h postapplication period. The application area was also tape-stripped to determine if any of the test material accumulated in the stratum corneum. These samples provided data that permitted some insight into the kinetics of penetration and elimination processes of MGK R11. Urine samples, swabs, and skin rinse samples were analyzed by high-performance liquid chromatography (HPLC) to characterize the metabolic profile, identify the major metabolites, and determine the metabolic pathway.

MGK R11, either by itself or formulated, was poorly absorbed through the skin as shown by the amount of radioactivity excreted in the urine and the very low plasma radioactivity level in the ipsilateral plasma. When dosed by itself, approximately 8% of the dose was excreted in the urine. In contrast, only 3% of the formulated MGK R11 was excreted in the urine. Approximately 0.3% of the dose was excreted in the feces. There was no evidence of accumulation of MGK R11 in the skin, as evidenced by low amounts of radioactivity in the tape strippings. A significant portion of the dosed radioactivity was recovered from the dome covering the dosing site amounting to 67% of the compound by itself or 27% of the formulated product, indicating a difference of volatility depending on the formulation. The rest of the external radioactivity was present in the swabs. Total recovery of the applied radioactivity was 89.9% and 99.5% for MGK R11 and the formulated product, respectively. Radiochemical analyses of the swab composites indicated a 30% degradation of parent compound in the one-component swabs and no degradation in the four-component swabs. Absorbed MGK R11 was completely metabolized prior to its excretion in the urine to two metabolites that accounted for 95% of the urinary metabolites. The major metabolic pathway is by oxidation of the aldehyde to the corresponding acid or reduction of the aldehyde to the corresponding alcohol followed by conjugation to produce the glucuronide.     

Glyphosate Skin Binding, Absorption, Residual Tissue Distribution, and Skin Decontamination

Glyphosate Skin Binding, Absorption, Residual Tissue Distribution,and Skin Decontamination. Wester, R. C., Melendres, J., Sarason,R., McMaster, J., and Maibach, H. I. (1991). Fundam. Appl. Toxicol.16, 725–732. Glyphosate is a broad-spectrum postemergencetranslocated herbicide. Its interactions with skin and potentialsystemic availability through percutaneous absorption was studiedby skin binding, skin absorption, residual tissue distribution,and skin decontamination. Glyphosate in a final formulation(Roundup) undiluted and diluted with water 1:20 and 1:32, wouldnot partition into powdered human stratum corneum (<1%).In vitro percutaneous absorption through human skin into humanplasma as receptor fluid was no more than 2% over a concentrationrange of 0.5–154 µg/cm² and a topical volume rangeof 0.014–0.14 ml/cm². Disposition of glyphosate followingiv administration of 93 and 9 µg doses to rhesus monkeyswas mainly through urine excretion, 95 ± 8 and 99 ±4% in 7 days, respectively. Percutaneous absorption in vivoin rhesus monkey was 0.8 ± 0.6% for the low dose (25µg/cm²) and 2.2 ± 0.8% for the high dose (270 µg/cm²).No residual ¹⁴C was found in organs of the monkeys euthanized7 days after the topical application. Washing the skin applicationsite with soap and water removed 90 ± 4% of applied dose,and washing with water only removed 84 ± 3% of applieddose. Both soap and water and water only were equal in abilityto remove glyphosate from skin over a 24 hr skin applicationperiod. About 50% of the initially applied dose could be recoveredafter 24 hr. Glyphosate is very soluble in water and insolublein most organics (octanol/water log P = –1.70) and thereforenot compatible with the lipid-laden stratum corneum. This isconsistent with the low skin binding and skin absorption andalso consistent with the efficient removal from skin with soapand water or water-only wash.     

Studies on benzyl acetate. III. The percutaneous absorption and disposition of [methylene-14C]benzyl acetate in the rat

[methylene-14C]Benzyl acetate was applied over an area of 6.25, 12 or 18 cm2 to the shaved backs of male Fischer 344 rats under an occlusive dressing at dose levels of 100, 250 and 500 mg/kg. The compound was administered either as the neat substance or as a 50% (v/v) solution in ethanol. After 6 hr the dressing was removed, the shaven area was washed with ethanol and the dressing and washings were counted for 14C. Urine and faeces were collected for 72 hr from the start of treatment and urinary metabolites were assayed by radio-TLC and HPLC. Following administration of the neat compound, a significant proportion of the dose was recovered from the application site (28-48%) and a similar proportion (28-46%) was absorbed and excreted in the 0-24-hr urine. Excretion of 14C in the urine over 0-24 hr accounted for c. 95% of absorbed 14C in all cases, and total recovery of radioactivity was 79-84% with less than 2% of the dose present in the carcass at the end of the experiments. The extent of absorption of benzyl acetate per unit area of skin, as assessed by the recovery of its metabolites in urine, rose with increasing concentration (mg/cm2) of the test compound on the skin. The absorption of topically applied benzyl acetate was essentially the same when the dose was administered in a 50% ethanolic solution. In all cases, the major urinary metabolite was hippuric acid (c. 95% of urinary 14C), together with much smaller amounts of benzoyl glucuronide, benzoic acid and benzylmercapturic acid. The distribution of 14C in the tissues was examined 6 and 24 hr after the topical application of 5 mg [methylene-14C]benzyl acetate/kg as a 1% (v/v) solution in ethanol to rats. Radioactivity in all carcasses was less than 4% of the administered dose and levels in all the organs examined were lower at 24 than at 6 hr.     

Dermal Absorption of Phthalate Diesters in Rats

Dermal Absorption of Phthalate Diesters in the Rat. ELSISI,A. E., CARTER, D. E., AND SIPES, I. G. (1989). Fundam Appl.Toxicol. 12, 70–77. This study examined the extent ofdermal absorption of a series of phthalate diesters in the rat.Those tested were dimethyl, diethyl, dibutyl, diisobutyl, dihexyl,di(2-ethylhexyl), diisodecyl, and benzyl butyl phthalate. Hairfrom a skin area (1.3cm in diameter) on the back of male F344rats was clipped, the [¹⁴C]phthalate diester was applied ina dose of 157 µmol/kg, and the area of application wascovered with a perforated cap. The rat was restrained and housedfor 7 days in a metabolic cage that allowed separate collectionof urine and feces. Urine and feces were collected every 24hr, and the amount of [¹⁴C] excreted was taken as an index ofthe percutaneous absorption. At 24 hr. diethyl phthalate showedthe greatest excretion (26%). As the length of the alkyl sidechain increased, the amount of [¹⁴C] excreted in the first 24hr decreased significantly. The cumulative percentage dose excretedin 7 days was greatest for diethyl, dibutyl, and diisobutylphthalate, about 50–60% of the applied ¹⁴C; and intermediate(20–40%) for dimethyl, benzyl butyl, and dihexyl phthalate.Urine was the major route of excretion of all phthalate diestersexcept for diisodecyl phthalate. This compound was poorly absorbedand showed almost no urinary excretion. After 7 days, the percentagedose for each phthalate that remained in the body was minimaland showed no specific tissue distribution. Most of the unexcreteddose remained in the area of application. These data show thatthe structure of the phthalate diester determines the degreeof dermal absorption. Absorption maximized with diethyl phthalateand then decreased significantly as the alkyl side chain lengthincreased.     

Percutaneous absorption, biotransformation, retention and excretion of 1,3-diaminobenzene in the rat

Groups of seven male Wistar rats were dermally exposed for 24 hr to 556 mumol [14C]meta-phenylenediamine (MPD; 1,3-diaminobenzene) in either aqueous solution (Group 2) or 4% hydrogen peroxide (Group 3). The percutaneous absorption and the amount of non-excreted radioactivity were significantly higher in Group 2 rats. Radioactivity associated with DNA purified from the liver and kidneys was demonstrated. Urine was the principal route of excretion, especially in Group 2 rats. Rats in Group 3 excreted significantly more MPD in the faeces than did Group 2 rats. Urinary excretion of material that constituted two of the peaks in the high-performance liquid chromatogram demonstrated first-order elimination kinetics. Three N-acetylated metabolites (N-acetyl-1,3-diaminobenzene, N,N'-diacetyl-2,4-diaminophenol and N,N'-diacetyl-1,3-diaminobenzene) accounted for 49 and 37% of the urinary excretion of group 2 and 3 rats, respectively, indicating that such metabolites represent important pathways in the metabolism of MPD. Minor excretion of at least one highly hydrophilic, unidentified metabolite of MPD was demonstrated. High-performance liquid chromatographic analysis of urine indicated that the XAD-2 purification procedure, which is usually used before mutagenicity testing in vitro, resulted in some of the radioactive materials being discarded. The percutaneous absorption of MPD in vivo was compared with the permeability of isolated epidermal membranes in vitro. These studies showed that such in vitro studies might be used to predict the dermal absorption by rats, in vivo, of MPD and similar, topically applied compounds.     

Induction of urinary excretion of 3-nitrotyrosine, a marker of oxidative stress, following administration of pyridostigmine bromide, DEET (N,N-diethyl-m-toluamide) and permethrin, alone and in combination in rats

In this study, we determined levels of 3-nitrotyrosine in rat urine following administration of a single oral dose of 13 mg/kg pyridostigmine bromide (PB) (3-dimethylaminocarbonyloxy-N-methylpyridinum bromide), a single dermal dose of 400 mg/kg N,N-diethyl-m-toluamide (DEET) and a single dermal dose of 1.3 mg/kg permethrin, alone and in combination. Urine samples were collected from five treated and five control rats at 4, 8, 16, 24, 48, and 72 h following dosing. Solid-phase extraction coupled with high-performance liquid chromatography with ultraviolet detection at 274 nm was used for the determination of tyrosine and 3-nitrotyrosine. A single oral dose of PB and a single dermal dose of DEET or their combination significantly (P<0.05) increased levels of 3-nitrotyrosine starting 24 h after dosing compared with control urine samples. The maximum increase of 3-nitroytyrosine was detected 48 h after combined administration of PB and DEET. The ratio of 3-nitrotyrosine to tyrosine in urine excreted 48 h after dosing was 0.19+/-0.04, 0.20+/-0.05, 0.28+/-0.03, 0.32+/-0.04, 0.19+/-0.05, 0.42+/-0.04, 0.27+/-0.03, 0.36+/-0.04, and 0.48+/-0.04 following administration of water, ethanol, PB, DEET, permethrin, PB+DEET, PB+permethrin, DEET+permethrin, and PB+DEET+permethrin, respectively. The results indicate that an oral dose of PB and a dermal administration of DEET, alone and in combination, could generate free radical species, and thus increase levels of 3-nitrotyrosine in rat urine. Induction of 3-nitrotyrosine, a marker of oxidative stress, following exposure to these compounds could be significant in understanding the proposed enhanced toxicity following combined exposure to these compounds.     

Percutaneous Absorption and Excretion of Alacholr in Rhesus Monkeys

Percutaneous Absorption and Excretion of Alachlor in RhesusMonkeys. KRONENBERG, J. M., FUHREMANN, T. W., AND JOHNSON, D.E., (1988) Fundam Appl Toxicol 10, 664–671. The percutaneousabsorption and excretion profile of alachlor were evaluatedin rhesus monkeys. A preliminary study demonstrated that anaverage of 86.7 and 9.7% of the administered dose was recoveredin the urine and feces, respectively, following intravenousadministration of radiolabeled alachlor to rhesus monkeys. Insubsequent studies, diluted and undiluted emulsifiable concentrate(EC) and microencapsulated (ME) formulations of radiolabeledalachlor were applied to a 40-cm² shaved abdominal area andallowed to remain on the skin for 12 hr. The radioactivity excretionprofiles in all animals were comparable. In all cases, approximately88% of the absorbed dose was eliminated via the urine, primarilywithin the first 48 hr. Comparison of the amount of radiolabelrecovered in the topical studies with that recovered followingintravenous administration indicated that an average of 8.5and 3.7% of the alachlor in the topically applied EC and MEformulations, respectively, was absorbed.     

Disposition of citral in male Fischer rats

The disposition of citral, an essential oil occurring in many foods and fragrances, was studied in male Fischer rats after iv, po, and dermal treatments. The pattern of distribution and elimination was the same after iv or oral exposure. Urine was the major route of elimination of citral-derived radioactivity, followed by feces, 14CO2, and expired volatiles. However, after dermal exposure, relatively less of the material was eliminated in the urine and more in the feces, suggesting a role for first-pass metabolism through the skin. Citral was almost completely absorbed orally; due to its extreme volatility, much of an applied dermal dose was lost. The citral remaining on the skin was fairly well absorbed. No effect of oral dose, from 5 to 500 mg/kg, was detected on disposition. Although the feces was a minor route of excretion, approximately 25% of the administered dose was eliminated via the bile within 4 hr of an iv dose. The metabolism of citral was both rapid and extensive. Within 5 min of an iv dose, no unmetabolized citral could be detected in the blood. Repeated exposure to citral resulted in an increase in biliary elimination, without any significant change in the pattern of urinary, fecal, or exhaled excretion. This suggests that citral may induce at least one pathway of its own metabolism. The rapid metabolism and excretion of this compound suggest that significant bioaccumulation of citral would not occur.     

Neurotoxicity Evaluation of N,N-Diethyl-m-toluamide (DEET) in Rats

The neurotoxic potential of N,N-diethyl-m-toluamide (DEET) wasevaluated following acute oral administration or following multigenerationplus chronic dietary administration to the rat. For the acutestudy, rats were administered undiluted DEET at dose levelsof 50, 200, or 500 mg/kg by gavage. A dose level of 500 mg/kgwas considered to be the highest practical dose that could beevaluated in this study based upon observations of overt toxicityat 500 mg/kg and mortality at 1000 mg/ kg in a dose range-findingstudy. The two measures of neurotoxicity evaluated in the acutestudy were functional observational battery (FOB) and motoractivity measurements. An apparent treatment-related effectin thermal response time (increased) was noted for both sexes1 hr after dosing at the 500 mg/kg dose level. A questionableeffect on rearing activity (decreased) also was noted at thesame dose level. For the multigeneration plus chronic dietaryadministration study, rats were administered DEET at dietaryconcentrations of 0, 500, 2000, or 5000 ppm continuously overtwo generations and then chronically for 9 months. A dietaryconcentration of 5000 ppm meets the criteria for a maximum tolerateddose (MTD) based on traditional chronic toxicology assessments.Evaluations included FOB, motor activity, discriminative acquisitionand reversal in an Mmaze, acoustic startle habituation, passiveavoidance acquisition and retention, and microscopic examinationof central and peripheral nervous tissue. The only effect thatwas considered to be possibly treatment-related was a slightincrease in exploratory locomotor activity at the 5000 ppm doselevel. Based on the results of these studies, the nervous systemdoes not appear to be a selective target when DEET is administeredto rats either as a single oral dose at high dose levels orchronically at the MTD.     

Increased 8-hydroxy-2'-deoxyguanosine, a biomarker of oxidative DNA damage in rat urine following a single dermal dose of DEET (N, N-diethyl-m-toluamide), and permethrin, alone and in combination

Levels of the biomarker of DNA oxidative damage 8-hydroxy-2'-deoxyguanosine (8-OHdG) in rat urine following dermal exposure to DEET (N,N-diethyl-m-toluamide) and permethrin, alone and in combination have been determined. A group of five rats for each time point were treated with a single dermal dose of 400 mg/kg of DEET, 1.3 mg/kg of permethrin or their combination. Urine samples were collected 2,4,8,16,24,48, and 72 h following application. Control urine samples of rats treated with ethanol were also collected at the same time intervals. Solid phase extraction coupled with high performance liquid chromatography (HPLC) with UV detection at 254 nm was used for determination of 2'-deoxyguanosine, and (8-OHdG). The limits of detection (LOD) were 0.5 ng of both 2'-deoxyguanosine and 8-OHdG. Their average percentage recoveries from urine samples were between 70-85%. A single dermal dose of DEET or in combination with permethrin significantly induced levels of (8-OHdG) that are excreted in the urine over the time course of the study compared to control urine samples. Permethrin did not cause significant increase in the amount of 8-OHdG in the urine. Levels of 8-OHdG in urine excreted at 24 h were 1009+/-342, 1701+/-321, 1140+/-316, and 1897+/-231 ng following treatment with ethanol, DEET, permethrin, and DEET+permethrin, respectively. The results indicate that dermal administration of DEET could generate free radical species hence cause DNA oxidative damage in rats.     

Percutaneous Absorption, Metabolism, and Hemolytic Activity of n-Butoxyethanol

Percutaneous Absorption, Metabolism, and Hemolytic Activityof n-Butoxyethanol. BARTNIK, F. G., REDDY, A. K., KLECAK, G.,ZIMMERMANN, V., HOSTYNEK, J. J., and KUNSTLER, K. (1987). Fundam.Appl. Toxicol. 8, 59–70. A series of studies was conductedto examine the percutaneous absorption, distribution, excretion,and hemolytic activity of n-butoxyethanol (BE). Rats receivinga subcutaneous dose of ¹⁴C-labeled BE excreted the radioactivityin the urine (79%), expired air (10%), and feces (0.5%) within72 hr. Of the organs analyzed, thymus and spleen showed elevatedspecific radioactivities as compared with blood. A percutaneousapplication of BE on rats, under nonocclusive conditions, showed25–29% absorption within 48 hr. Peak blook levels of BEoccurred at 2 hr after application; butoxyacetic acid (BAA)was found to be the major metabolite. Comparison of in vitroskin penetration data showed the following absorption patternof BE: hairless rat >> pig > human skin. Hemolysisand associated hematological changes were noted in the ratswhich received single dermal applications of 260–500 mg/kgof BE. In vitro, BAA showed markedly greater hemolytic abilityon rat erythrocytes than did BE. Human erythrocytes showed nohemolysis when incubated with BE or BAA at concentrations thatare hemolytic to rat erythrocytes. An intravenous dose of 62.5mg/kg of BE does not result in hemolysis or hemoglobinuria inthe rat. The rat may be an animal model with increased susceptibilityto the effects of BE compared with humans because of its rapidpercutaneous absorptive ability and its greater hemolytic sensitivity.     

Effect of dose on the percutaneous absorption of 2- and 4-chloronitrobenzene in rats.

The effect of dose on the dermal absorption of 2- and 4-chloronitrobenzene (2- and 4-CNB) has been investigated in rats following nonocclusive protective dermal application on an area of 4 cm2 per animal at approximately 0.0325, 0.325, and 3.25 mg/cm2 (0.65, 6.5, and 65 mg/kg, respectively). At the three-dose levels, 33-40% and 51-62% of the dose of 2- and 4-CNB, respectively, was absorbed from the skin within 72 hr. The balance of the dose was recovered in the protective device and the organic trap (i.e. that portion unavailable for dermal absorption). The absorbed radioactivity was excreted in urine (21-28% of dose, 2-CNB; 43-45%, 4-CNB) and feces (11-15%, 2-CNB; 5-12%, 4-CNB). The extent and rate of dermal absorption and urinary and fecal excretion of 2-CNB were linear over the 0.65-65 mg/kg dose range; for 4-CNB they were linear over the 0.65-6.5 mg/kg dose, and nonlinear at the 65 mg/kg dose.